Our leadership team is looking forward to attending and presenting at the Jefferies Cell & Genetic Medicine Summit and sharing details of our progress advancing the next wave of precision genetic medicines.

ReCode leadership will provide updates on our PCD and CF programs as well as our selective organ targeting (SORT) platform.

We’re excited to participate in the Morgan Stanley Annual Global Healthcare Conference in New York. This event is a key gathering of healthcare professionals and innovators from around the globe.

We look forward to shaping the future of genetic medicines alongside other industry leaders.

We’ll be at the 2nd Next Gen Lipid-Based Nanoparticles Delivery Summit, helping provide a complete picture of the lipid-based delivery landscape.